迪奥辛通过抑制质瘤中RBM47和NF-κB之间的正反循环来降低M2两极化
Jialing Bai1, Xinxiang Zhang1, Wanyao Meng1
1Department of Pharmacology, Life Science and Biopharmaceutical Institution, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning Province, PR China.
概括
迪奥辛是一种天然化合物,通过准RBM47-NF-κB反循环来对抗质母细胞瘤 (GBM). 这破坏了免疫抑制瘤微环境,提供了潜在的新型GBM疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 质母细胞瘤 (GBM) 的微环境对瘤的进展产生了关键的影响.
- 用新的治疗方法准血脑屏障对于GBM治疗至关重要.
- 植物性氨酸 Dioscin 穿透了血脑屏障,并表现出抗瘤特性,但其对 GBM 微环境的影响尚不清楚.
研究的目的:
- 为了研究迪奥斯对质母细胞瘤微环境的影响.
- 阐明底层的分子机制在GBM的迪奥辛的抗瘤活性.
- 探索RBM47和NF-κB在GBM免疫抑制中的作用,以及它们通过迪奥辛的调节.
主要方法:
- 对GBM患者数据和预后进行生物信息学分析.
- 在体外和体内对巨分极和细胞的评估.
- 通过RNA测序,免疫光,西斑,RIP和CHIP测试来确定分子机制.
- 研究RBM47-NF-κB通路及其由迪奥辛的调节.
主要成果:
- 迪奥辛抑制了M2巨细胞的两极分化,并在GBM中增强了巨细胞的细胞化.
- 高RBM47表达与不良的GBM患者预后相关,并与免疫反应有关.
- 迪奥辛破坏了RBM47-NF-κB正反循环,降低了炎症基因表达和蛋白质水平的调节.
- RBM47通过NF-κB激活稳定炎症基因mRNA,从而导致免疫抑制的GBM微环境.
结论:
- 在RBM47和NF-κB之间的正反循环促进了免疫抑制的GBM微环境.
- 迪奥辛通过破坏这个RBM47-NF-κB循环,有效地抑制GBM中的M2极化.
- 迪奥辛通过调节瘤免疫微环境,证明了对GBM治疗的显著治疗潜力.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


